Activin and Inhibin

DS45500853 is an estrogen-related receptor α ( ERRα ) agonist. DS45500853 inhibits the binding between receptor-interacting protein 140 (RIP140) corepressor peptide (10 nM) and GST-ERRα ligand-binding domain (LBD: 1.2 μM) with an IC 50 value of 0.80

DS45500853 is an estrogen-related receptor α ( ERRα ) agonist. DS45500853 inhibits the binding between receptor-interacting protein 140 (RIP140) corepressor peptide (10 nM) and GST-ERRα ligand-binding domain (LBD: 1.2 μM) with an IC 50 value of 0.80

DS45500853 is an estrogen-related receptor α ( ERRα ) agonist. DS45500853 inhibits the binding between receptor-interacting protein 140 (RIP140) corepressor peptide (10 nM) and GST-ERRα ligand-binding domain (LBD: 1.2 μM) with an IC 50 value of 0.80

DS45500853 is an estrogen-related receptor α ( ERRα ) agonist. DS45500853 inhibits the binding between receptor-interacting protein 140 (RIP140) corepressor peptide (10 nM) and GST-ERRα ligand-binding domain (LBD: 1.2 μM) with an IC 50 value of 0.80

DSHS00884 is a potent human papillomavirus E6 inhibitor with an IC 50 of 10 μMIn VitroDSHS00884 stabilizes p53 levels in HPV-positive cells by blocking E6-mediated p53 degradation with an IC 50 of 2.5-25 μM. MCE has not independently confirmed the

DSHS00884 is a potent human papillomavirus E6 inhibitor with an IC 50 of 10 μMIn VitroDSHS00884 stabilizes p53 levels in HPV-positive cells by blocking E6-mediated p53 degradation with an IC 50 of 2.5-25 μM. MCE has not independently confirmed the

DSHS00884 is a potent human papillomavirus E6 inhibitor with an IC 50 of 10 μMIn VitroDSHS00884 stabilizes p53 levels in HPV-positive cells by blocking E6-mediated p53 degradation with an IC 50 of 2.5-25 μM. MCE has not independently confirmed the

DSHS00884 is a potent human papillomavirus E6 inhibitor with an IC 50 of 10 μMIn VitroDSHS00884 stabilizes p53 levels in HPV-positive cells by blocking E6-mediated p53 degradation with an IC 50 of 2.5-25 μM. MCE has not independently confirmed the

DSHS00884 is a potent human papillomavirus E6 inhibitor with an IC 50 of 10 μMIn VitroDSHS00884 stabilizes p53 levels in HPV-positive cells by blocking E6-mediated p53 degradation with an IC 50 of 2.5-25 μM. MCE has not independently confirmed the

DSM265 is a long-duration inhibitor of P. falciparum dihydroorotate dehydrogenase ( Pf DHODH ) with an IC 50 of 8.9 nM. DSM265 can also inhibit the growth of Pf 3D7 parasites with an EC 50 of 4.3 nMIn VivoDSM265 (0.5 to 75 mg/kg: Oral

DSM265 is a long-duration inhibitor of P. falciparum dihydroorotate dehydrogenase ( Pf DHODH ) with an IC 50 of 8.9 nM. DSM265 can also inhibit the growth of Pf 3D7 parasites with an EC 50 of 4.3 nMIn VivoDSM265 (0.5 to 75 mg/kg: Oral

DSM265 is a long-duration inhibitor of P. falciparum dihydroorotate dehydrogenase ( Pf DHODH ) with an IC 50 of 8.9 nM. DSM265 can also inhibit the growth of Pf 3D7 parasites with an EC 50 of 4.3 nMIn VivoDSM265 (0.5 to 75 mg/kg: Oral